Sophia G Antimisiaris

Summary

Affiliation: University of Patras
Country: Greece

Publications

  1. ncbi In-vitro antileishmanial and trypanocidal activities of arsonoliposomes and preliminary in-vivo distribution in BALB/c mice
    Sophia G Antimisiaris
    Department of Pharmacy, Laboratory of Pharmaceutical Technology, University of Patras, Rio 26500, Greece
    J Pharm Pharmacol 55:647-52. 2003
  2. ncbi In vivo distribution of arsonoliposomes: effect of vesicle lipid composition
    Paraskevi Zagana
    Laboratory of Pharmaceutical Technology, Department of Pharmacy, University of Patras, 26500 Rio, Greece
    Int J Pharm 347:86-92. 2008
  3. ncbi PLGA, chitosan or chitosan-coated PLGA microparticles for alveolar delivery? A comparative study of particle stability during nebulization
    Maria Letizia Manca
    Laboratory of Pharmaceutical Technology, Department of Pharmacy, University of Patras, Rio 26510, Greece
    Colloids Surf B Biointerfaces 62:220-31. 2008
  4. ncbi Liposomes for drug delivery to the lungs by nebulization
    Marco Zaru
    Department of Pharmacy, University of Patras, Rio, Greece
    Eur J Pharm Biopharm 67:655-66. 2007
  5. ncbi Release of rifampicin from chitosan, PLGA and chitosan-coated PLGA microparticles
    Maria Letizia Manca
    Laboratory of Pharmaceutical Technology, Department of Pharmacy, University of Patras, Rio 26510, Greece
    Colloids Surf B Biointerfaces 67:166-70. 2008
  6. ncbi Chitosan-coated liposomes for delivery to lungs by nebulisation
    Marco Zaru
    Laboratory of Pharmaceutical Technology, Department of Pharmacy, University of Patras, Rio 26510, Greece
    Colloids Surf B Biointerfaces 71:88-95. 2009
  7. ncbi Complex hydrogel systems composed of polymers, liposomes, and cyclodextrins: implications of composition on rheological properties and aging
    Spyridon Mourtas
    Laboratory of Pharmaceutical Technology, Department of Pharmacy, School of Health Sciences, University of Patras, 26510 Rio, Greece
    Langmuir 25:8480-8. 2009
  8. ncbi Dexamethasone incorporating liposomes: effect of lipid composition on drug trapping efficiency and vesicle stability
    Vassilios Athanassios Tsotas
    Laboratory of Pharmaceutical Technology, Department of Pharmacy, School of Health Sciences, University of Patras, Rio, Greece
    Drug Deliv 14:441-5. 2007
  9. ncbi Liposomal drugs dispersed in hydrogels. Effect of liposome, drug and gel properties on drug release kinetics
    Spyridon Mourtas
    Laboratory of Pharmaceutical Technology, Department of Pharmacy, School of Health Sciences, University of Patras, 26510 Rio, Greece
    Colloids Surf B Biointerfaces 55:212-21. 2007
  10. ncbi Integrity of liposomes in presence of various formulation excipients, when dispersed in aqueous media and in hydrogels
    Spyridon Mourtas
    Laboratory of Pharmaceutical Technology, Department of Pharmacy, School of Health Sciences, University of Patras, 26510 Rio, Greece
    Colloids Surf B Biointerfaces 61:270-6. 2008

Collaborators

  • Panayiotis V Ioannou
  • Dimitrios G Fatouros
  • Evangelia Papadimitriou
  • Babette Weksler
  • Philippe M Loiseau
  • Dimitris Karnabatidis
  • Dimitris Siablis
  • Francesco Nicotra
  • Olga Gortzi
  • Spyridon Mourtas
  • Maria Letizia Manca
  • Paraskevi Zagana
  • Marco Zaru
  • Anna Maria Fadda
  • Pavlos Klepetsanis
  • Eleni Markoutsa
  • Sophia Piperoudi
  • Maria Haikou
  • Paraskevi Kallinteri
  • Anna Niarakis
  • Athanasios Skouras
  • Eleftheria Giannopoulou
  • Catalina Peptu
  • Styliani Fotopoulou
  • Stela Duraj
  • Yannis F Missirlis
  • Christos Tsakiroglou
  • Panayiota Hatzi
  • Vassilios Athanassios Tsotas
  • Sotirios Koutsopoulos
  • Vassiliki Ntimenou
  • Maria N Haikou
  • Georgia Koromila
  • Peter Frederik
  • Marco Gobbi
  • Pierre Olivier Couraud
  • Barbara La Ferla
  • Sarah Catoen
  • Georgios Pampalakis
  • Claire Wallon
  • Ignacio A Romero
  • Dario Aurilia
  • Mara Canovi
  • Mario Salmona
  • Marie Christine De Goltstein
  • Cristiano Zona
  • Christos A Aggelopoulos
  • Christos D Tsakiroglou
  • Georgios P A K Michanetzis
  • Vassileios Dracopoulos
  • Marcel Popa
  • Giuseppe Loy
  • Maria-Letizia Manca
  • Maria Theodoropoulou
  • Vassiliki Sfika
  • Vassilios-Athanassios Tsotas
  • Pavlos G Klepetsanis
  • Emmanouil V Christodoulakis
  • George P A Michanetzis
  • Miltiadis Tsilimbaris
  • Irene Tsota
  • Christina Kalogeropoulou

Detail Information

Publications34

  1. ncbi In-vitro antileishmanial and trypanocidal activities of arsonoliposomes and preliminary in-vivo distribution in BALB/c mice
    Sophia G Antimisiaris
    Department of Pharmacy, Laboratory of Pharmaceutical Technology, University of Patras, Rio 26500, Greece
    J Pharm Pharmacol 55:647-52. 2003
    ....
  2. ncbi In vivo distribution of arsonoliposomes: effect of vesicle lipid composition
    Paraskevi Zagana
    Laboratory of Pharmaceutical Technology, Department of Pharmacy, University of Patras, 26500 Rio, Greece
    Int J Pharm 347:86-92. 2008
    ..This proves that arsonoliposome lipid composition (and consequently their integrity) influences their pharmacokinetic profile. Thus, the proper arsonoliposome composition should be used according to the intended application...
  3. ncbi PLGA, chitosan or chitosan-coated PLGA microparticles for alveolar delivery? A comparative study of particle stability during nebulization
    Maria Letizia Manca
    Laboratory of Pharmaceutical Technology, Department of Pharmacy, University of Patras, Rio 26510, Greece
    Colloids Surf B Biointerfaces 62:220-31. 2008
    ..50% or 0.75% CHT exhibited highest EE% for RIF and also best nebulization ability and stability, compared to all other MP formulations studied. Additionally they had good mucoadhesive properties and comparably low cytotoxicity...
  4. ncbi Liposomes for drug delivery to the lungs by nebulization
    Marco Zaru
    Department of Pharmacy, University of Patras, Rio, Greece
    Eur J Pharm Biopharm 67:655-66. 2007
    ..Mucoadhesion and A549 cell toxicity studies were in line with this conclusion, however if mucoadhesion is required, improvement may be needed...
  5. ncbi Release of rifampicin from chitosan, PLGA and chitosan-coated PLGA microparticles
    Maria Letizia Manca
    Laboratory of Pharmaceutical Technology, Department of Pharmacy, University of Patras, Rio 26510, Greece
    Colloids Surf B Biointerfaces 67:166-70. 2008
    ..40 the release was faster from the CHT-coated particles. Concluding, it is proven that when PLGA MPs are coated with CHT, in addition to increased particle mucoadhesive properties, the release kinetics of RIF are modified...
  6. ncbi Chitosan-coated liposomes for delivery to lungs by nebulisation
    Marco Zaru
    Laboratory of Pharmaceutical Technology, Department of Pharmacy, University of Patras, Rio 26510, Greece
    Colloids Surf B Biointerfaces 71:88-95. 2009
    ..Thereby, it is concluded that CHT-coated liposomes have advantages (compared to non-coated) when the delivery of drugs to the lungs by nebulisation is considered...
  7. ncbi Complex hydrogel systems composed of polymers, liposomes, and cyclodextrins: implications of composition on rheological properties and aging
    Spyridon Mourtas
    Laboratory of Pharmaceutical Technology, Department of Pharmacy, School of Health Sciences, University of Patras, 26510 Rio, Greece
    Langmuir 25:8480-8. 2009
    ..Gels with a high CD concentration (400 mg/mL) are almost insensitive to aging, whereas all other gels become slightly more elastic and less viscous as aging proceeds...
  8. ncbi Dexamethasone incorporating liposomes: effect of lipid composition on drug trapping efficiency and vesicle stability
    Vassilios Athanassios Tsotas
    Laboratory of Pharmaceutical Technology, Department of Pharmacy, School of Health Sciences, University of Patras, Rio, Greece
    Drug Deliv 14:441-5. 2007
    ....
  9. ncbi Liposomal drugs dispersed in hydrogels. Effect of liposome, drug and gel properties on drug release kinetics
    Spyridon Mourtas
    Laboratory of Pharmaceutical Technology, Department of Pharmacy, School of Health Sciences, University of Patras, 26510 Rio, Greece
    Colloids Surf B Biointerfaces 55:212-21. 2007
    ..The same is true for calcein in liposomal gels. Carbopol gel rheological properties were found to be significantly different (compared to the other gels), implying that these characteristics are important for drug diffusion from gels...
  10. ncbi Integrity of liposomes in presence of various formulation excipients, when dispersed in aqueous media and in hydrogels
    Spyridon Mourtas
    Laboratory of Pharmaceutical Technology, Department of Pharmacy, School of Health Sciences, University of Patras, 26510 Rio, Greece
    Colloids Surf B Biointerfaces 61:270-6. 2008
    ..Conclusively, the results of this study suggest that liposomes are protected from excipients when dispersed in gels compared to aqueous media. This should be taken into account when liposomal drug formulations are designed...
  11. ncbi Integrity of liposomes in presence of cyclodextrins: effect of liposome type and lipid composition
    Panayiota Hatzi
    Laboratory of Pharmaceutical Technology, Department of Pharmacy, School of Health Sciences, University of Patras, Rio 26500, Patras, Greece
    Int J Pharm 333:167-76. 2007
    ..Turbidity measurements confirm that DRV liposomes are affected more than SUV...
  12. ncbi Arsenic trioxide liposomes: encapsulation efficiency and in vitro stability
    Paraskevi Kallinteri
    Laboratory of Pharmaceutical Technology, Department of Pharmacy, University of Patras, Rio, Greece
    J Liposome Res 14:27-38. 2004
    ....
  13. ncbi Does the lipid membrane composition of arsonoliposomes affect their anticancer activity? A cell culture study
    Paraskevi Zagana
    Laboratory of Pharmaceutical Technology, Department of Pharmacy, University of Patras, Patras, Greece
    Mol Nutr Food Res 53:592-9. 2009
    ..Thereby it is concluded that arsonoliposome composition should be adjusted in accordance to their in vivo kinetics and the desired, for each specific application, biodistribution of As and/or encapsulated drug...
  14. ncbi Arsonoliposomes: effect of arsonolipid acyl chain length and vesicle composition on their toxicity towards cancer and normal cells in culture
    Olga Gortzi
    Department of Pharmacy, University of Patras, Rio 26500, Patras, Greece
    Eur J Pharm Sci 18:175-83. 2003
    ....
  15. ncbi The effect of added liposomes on the rheological properties of a hydrogel: a systematic study
    Spyridon Mourtas
    Laboratory of Pharmaceutical Technology, Department of Pharmacy, School of Health Sciences, University of Patras, 26510 Rio, Greece
    J Colloid Interface Sci 317:611-9. 2008
    ..Concluding, liposome composition (membrane rigidity) and lipid concentration, but not liposome size, seem to be very important factors that determine the rheological modulations caused by liposome addition in gels...
  16. ncbi Incorporation of PEG-lipids in arsonoliposomes results in formation of highly stable arsenic-containing vesicles
    Sophia Piperoudi
    Laboratory of Pharmaceutical Technology, Department of Pharmacy, School of Health Sciences, University of Patras, Rio 26500, Patras, Greece
    Chem Phys Lipids 139:96-106. 2006
    ..In addition to high membrane integrity, the high content pegylated arsonoliposomes are morphologically perfect round-shaped vesicles without the sharp edges typically observed with non-pegylated DSPC-containing arsonoliposomes...
  17. ncbi Arsonoliposomes: preparation and physicochemical characterization
    Sophia G Antimisiaris
    Laboratory of Pharmaceutical Technology, Department of Pharmacy, University of Patras, and FORTH Institute of Chemical Engineering, Patras, Greece
    Methods Mol Biol 605:147-62. 2010
    ..Herein, we describe in detail the preparation and physicochemical characterization of ARSL...
  18. ncbi Arsonoliposome interaction with thiols: effect of pegylation and arsonolipid content of arsonoliposomes on their integrity during incubation in glutathione
    Maria N Haikou
    Laboratory of Pharmaceutical Technology, Department of Pharmacy, University of Patras, Rio 26500, Patras, Greece
    J Nanosci Nanotechnol 6:2974-8. 2006
    ....
  19. ncbi Arsonoliposomes: effect of lipid composition on their stability and morphology
    Sophia Piperoudi
    Laboratory of Pharmaceutical Technology, Department of Pharmacy, University of Patras, Patras, Greece
    J Liposome Res 15:187-97. 2005
    ..The latter arsonoliposomes provide a system that may be used for combining arsonolipid activity with the activity of other drugs...
  20. ncbi Haemolytic activity of liposomes: effect of vesicle size, lipid concentration and polyethylene glycol-lipid or arsonolipid incorporation
    Spyridon Mourtas
    Laboratory of Pharmaceutical Technology, Department of Pharmacy, School of Health Sciences, University of Patras, 26510 Rio, Greece
    J Biomed Nanotechnol 5:409-15. 2009
    ..Nevertheless, at concentrations which are relevant with liposomal drug administration in humans, all formulations tested demonstrated negligible haemolysis...
  21. ncbi Stability of protein-encapsulating DRV liposomes after freeze-drying: A study with BSA and t-PA
    Vassiliki Ntimenou
    Laboratory of Pharmaceutical Technology, Dept. of Pharmacy, University of Patras, Rio, 26510, Greece
    J Liposome Res 16:403-16. 2006
    ..Thereby, interactions between proteins and membranes determine not only the encapsulation efficiency but also the need for cryopreservation of liposomal protein formulations...
  22. ncbi In vivo distribution of arsenic after i.p. injection of arsonoliposomes in balb-c mice
    Sophia G Antimisiaris
    Laboratory of Pharmaceutical Technology, Department of Pharmacy, Rio 26500, Greece
    Int J Pharm 289:151-8. 2005
    ..No acute toxicity, or effect on the body or organ weight of the mice was observed...
  23. ncbi Uptake and permeability studies of BBB-targeting immunoliposomes using the hCMEC/D3 cell line
    Eleni Markoutsa
    Laboratory of Pharmaceutical Technology, Department of Pharmacy, University of Patras, Rio, Greece
    Eur J Pharm Biopharm 77:265-74. 2011
    ..Co-decoration with a second ligand slightly decreases OX-26-decorated vesicle uptake, but not transcytosis, proving that the biotin-streptavidin technique can be applied for the generation of dual-targeting nanoliposomes...
  24. ncbi Heparin incorporating liposomes as a delivery system of heparin from PET-covered metallic stents: effect on haemocompatibility
    Georgia Koromila
    Laboratory of Pharmaceutical Technology, Department of Pharmacy, School of Health Sciences, University of Patras, Rio 26510, Greece
    Biomaterials 27:2525-33. 2006
    ....
  25. ncbi Preparation of DRV liposomes
    Sophia G Antimisiaris
    Laboratory of Pharmaceutical Technology, Department of Pharmacy, University of Patras, and ICE HT FORTH, Patras, Greece
    Methods Mol Biol 605:51-75. 2010
    ....
  26. ncbi Stability and aggregation studies of non-sonicated arsonolipid-containing vesicles
    Dimitrios G Fatouros
    Laboratory of Pharmaceutical Technology, Department of Pharmacy, University of Patras, 26504, Greece
    Cell Mol Biol Lett 10:173-83. 2005
    ..Aggregation could not be always explained on the basis of zeta potential changes, indicating that the process is complex...
  27. ncbi Curcumin-decorated nanoliposomes with very high affinity for amyloid-?1-42 peptide
    Spyridon Mourtas
    Laboratory of Pharmaceutical Technology, Department of Pharmacy, University of Patras, Rio 26510, Patras, Greece
    Biomaterials 32:1635-45. 2011
    ..In summary, we describe here the preparation and characterization of new nanoparticles with a very high affinity for A?1-42 fibrils, to be exploited as vectors for the targeted delivery of new diagnostic and therapeutic molecules for AD...
  28. ncbi Release of liposome-encapsulated calcein from liposome entrapping gelatin-carboxymethylcellulose films: a presentation of different possibilities
    Catalina Peptu
    Laboratory of Pharmaceutical Technology, Department of Pharmacy, University of Patras, Rio 26510, Greece
    J Nanosci Nanotechnol 8:2249-58. 2008
    ..Film composition also affects the integrity of the film-entrapped liposomes during the crosslinking process, possibly due its effect on the density of the polymeric network of the film...
  29. ncbi Arsonoliposomes, a novel class of arsenic-containing liposomes: effect of palmitoyl-arsonolipid-containing liposomes on the viability of cancer and normal cells in culture
    Olga Gortzi
    Laboratory of Pharmaceutical Technology, University of Patras, Greece
    Pharm Res 19:79-86. 2002
    ..CONCLUSIONS: Considering the numerous advantages of liposomal systems in therapeutics, it is concluded that the arsonoliposome system is very interesting and future applications should be exploited by further studies...
  30. ncbi Effect of amphiphilic drugs on the stability and zeta-potential of their liposome formulations: a study with prednisolone, diazepam, and griseofulvin
    Dimitrios G Fatouros
    Laboratory of Pharmaceutical Technology, Department of Pharmacy, School of Health Sciences, University of Patras, Rio, 26500, Greece
    J Colloid Interface Sci 251:271-7. 2002
    ..Thereby, we may conclude that the previously demonstrated effects of the thiazides on liposome properties are not solely related to their structure...
  31. ncbi Magnetoliposomes with high USPIO entrapping efficiency, stability and magnetic properties
    Athanasios Skouras
    Laboratory of Pharmaceutical Technology, Dept of Pharmacy, School of Health Sciences, University of Patras, Patras, Greece
    Nanomedicine 7:572-9. 2011
    ..Targeted MLs retained their nanosize and integrity during storage for 1 month at 4 °C and up to 2 weeks at 37 °C...
  32. ncbi Dexamethasone incorporating liposomes: an in vitro study of their applicability as a slow releasing delivery system of dexamethasone from covered metallic stents
    Paraskevi Kallinteri
    Department of Pharmacy, Laboratory of Pharmaceutical Technology, University of Patras, Patras 26500, Greece
    Biomaterials 23:4819-26. 2002
    ..Further in vitro and in vivo studies are needed in order to exploit the possible applications of this methodology...
  33. ncbi Arsonoliposomes: novel nanosized arsenic-containing vesicles for drug delivery
    Dimitris G Fatouros
    Department of Pharmaceutics and Analytical Chemistry, The Danish University of Pharmaceutical Sciences, Universitetsparken 2, 2100, Copenhagen, Denmark
    J Nanosci Nanotechnol 6:2618-37. 2006
    ..From studies performed thus far it is concluded that arsonoliposomes are nanosized-vesicles with interesting properties that justify further exploitation towards the development of therapeutic systems for cancer or parasitic diseases...
  34. ncbi Thermal behavior of novel non-sonicated arsonolipid-containing liposomes
    Sotirios Koutsopoulos
    Center for Biomedical Engineering, Massachusetts Institute of Technology, 77 Massachusetts Avenue, Cambridge, 02139-4307, USA
    Biophys Chem 121:150-4. 2006
    ....